Newborn Clinical Trial
Official title:
Evaluation of Growth, Safety, and Efficacy of an Infant Formula for Healthy Term Infants
Verified date | June 2021 |
Source | ByHeart |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to demonstrate that a new infant formula for term infants supports age-appropriate growth. This study is designed in accordance with Good Clinical Practice guidelines and the requirements of the Code of Federal Regulations, 21CFR106.96. In this randomized, controlled trial (RCT), healthy, term, formula-fed (FF) infants will be randomized to one of two infant formulas: a standard, commercially-available infant formula for term infants (CF) or the study formula for term infants (SF) for 16 weeks. A reference group of human milk-fed infants will also be enrolled. The primary efficacy objective is to compare the growth of infants randomized to the study infant formula (SF) versus growth of infants randomized to the standard commercial infant formula (CF).
Status | Completed |
Enrollment | 311 |
Est. completion date | June 11, 2021 |
Est. primary completion date | June 11, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A to 14 Days |
Eligibility | Inclusion Criteria: - Term (no less than 37 weeks, 0 days and less than 42 weeks, 0 days), singleton infant. - Birth weight of greater than or equal to 2500 grams. - Designated healthy by a physician. - Less than or equal to 14 days of age at enrollment. - If formula fed, exclusively consuming and tolerating a cow's milk infant formula at enrollment and have a parent who agrees to feed the study formula as a sole source of nutrition for a minimum of 16 weeks. - If human milk fed, predominantly consuming and tolerating human milk and have a mother/parent who plans to predominantly feed human milk as sole source of nutrition for a minimum of 16 weeks. - Weight for age greater than or equal to 5th percentile and less than or equal to 95th percentile at enrollment. - Length for age greater than or equal to 5th percentile and less than or equal to 95th percentile at enrollment. - Head circumference for age greater than or equal to 5th percentile and less than or equal to 95th percentile at enrollment. - Weight for length greater than or equal to 5th percentile and less than or equal to 95th percentile at enrollment. - Not currently receiving and have a parent/guardian who does not plan to give pre- and/or pro-biotics for the full duration of the study. - Not currently participating in an interventional clinical trial and have a parent(s) or legal guardian(s) who agree not to enroll the infant in an interventional clinical trial while participating in this trial. - Have parent(s) or legal guardian(s) who are capable of completing the written records, questionnaires, and study procedures required by the protocol. - Have a parent(s) or legal guardian(s) who have read and voluntarily signed the Institutional Review Board Informed Consent prior to study participation. Exclusion Criteria: - Evidence of any anatomic or physiologic condition that would interfere with normal growth, development, or feeding. - Infants required to take medications know to influence growth and development. - Maternal history with known adverse effects on the fetus and/or the newborn infants. - Family history of cow milk protein allergy or soy intolerance/allergy. - Infants receiving any amount supplemental human milk with infant formula or visa-versa at time of enrollment. - Infants from a multiple birth. |
Country | Name | City | State |
---|---|---|---|
United States | Topaz Clinical Research | Apopka | Florida |
United States | San Gabriel Women's Health | Arcadia | California |
United States | Alabama Clinical Therapeutics | Birmingham | Alabama |
United States | HMG Primary Care at Sapling Grove | Bristol | Tennessee |
United States | Coastal Pediatric Research | Charleston | South Carolina |
United States | Pediatric Associates of Mt. Carmel, Inc | Cincinnati | Ohio |
United States | Optum | Colorado Springs | Colorado |
United States | Schear Family Practice | Dayton | Ohio |
United States | Pediatric Associates of Fairfield, Inc. | Fairfield | Ohio |
United States | Sarkis Clinical Trials | Gainesville | Florida |
United States | Houston Clinical Research Associates | Houston | Texas |
United States | Clinical Research Prime | Idaho Falls | Idaho |
United States | Jackson Clinic North | Jackson | Tennessee |
United States | The Children's Clinic of Jonesboro, P.A. | Jonesboro | Arkansas |
United States | HMG Pediatrics at Kingsport | Kingsport | Tennessee |
United States | Sierra Clinical Research | Las Vegas | Nevada |
United States | Tanner Clinic | Layton | Utah |
United States | Applied Research Center of Arkansas | Little Rock | Arkansas |
United States | DCOL Center for Clinical Research | Longview | Texas |
United States | Institute of Clinical Research | Mentor | Ohio |
United States | Avanza Medical Research | Pensacola | Florida |
United States | ACRC Trials Plano Pediatrics | Plano | Texas |
United States | Northern California Research | Sacramento | California |
United States | Coastal Pediatric Associates | Summerville | South Carolina |
United States | PAS-Research | Tampa | Florida |
United States | Watching Over Mothers and Babies | Tucson | Arizona |
United States | Southern Clinical Research | Zachary | Louisiana |
Lead Sponsor | Collaborator |
---|---|
ByHeart | Paidion Research, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Weight Gain Velocity | G/D | 0 - 16 weeks | |
Secondary | Weight Measures | KG | 0 - 16 weeks | |
Secondary | Length Measures | CM | 0 - 16 weeks | |
Secondary | Length Gain Velocity | CM/D | 0 - 16 weeks | |
Secondary | Head Circumference Measures | CM | 0 - 16 weeks | |
Secondary | Weight for age Z-scores | Weight for age Z-scores compared to World Health Organization (WHO) growth standards | 0 - 16 weeks | |
Secondary | Length for age Z-scores | Length for age Z-scores compared to WHO growth standards | 0 - 16 weeks | |
Secondary | Head circumference for age Z-scores | Head circumference for age Z-scores compared to WHO growth standards | 0 - 16 weeks | |
Secondary | Weight for length Z-scores | Weight for length Z-scores compared to WHO growth standards | 0 - 16 weeks | |
Secondary | 72-hr record of formula intake at each study visit | OZ/D | 0 - 16 weeks | |
Secondary | Blood concentrations of Interleukin-6 (pg/mL), Interleukin-10 (pg/mL), and tumor necrosis factor-alpha (pg/mL) | Concentration | 16 weeks | |
Secondary | Blood concentrations of amino acids (umol/L) | Concentration | 16 weeks | |
Secondary | Human milk composition (concentrations of proteins, lipids, carbohydrates, vitamins, and minerals | Concentration | 3 weeks, 7 weeks | |
Secondary | Medically-diagnosed adverse events collected throughout the study period | Frequency | 0 through 16 weeks | |
Secondary | Parent rating of infant stool consistency at each study visit | Mean. Quinlan et al Likert scale; 0=no bowel movement, 1=hard [dry hard pellets], 2=formed [definite shape, not dry], 3=soft [no definite shape, pasty], 4=loose [no shape, some water], 5=watery [no shape, mainly water]). | 0 - 16 weeks | |
Secondary | Parent report of infant stool frequency at each study visit | Mean | 0 - 16 weeks | |
Secondary | Parent report of infant disposition (fussiness, crying, gas, spit up, Infant Characteristics Questionnaire) at each study visit | Mean | 0 - 16 weeks | |
Secondary | Stool microbiome | Fecal microbial taxa and community abundance | 2 weeks, 16 weeks | |
Secondary | Stool metabolome | Targeted and Untargeted Metabolomics | 2 weeks, 16 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06350084 -
Effect of Mother's Touch and Nurse's Therapeutic Touch on Pain Level and Crying Time During Heel Blood Collection
|
N/A | |
Not yet recruiting |
NCT04441463 -
Simultaneous Study of the Serum Tryptase Level of the Mother and the Child During Childbirth (TryPla)
|
N/A | |
Not yet recruiting |
NCT04337229 -
Evaluation of Comfort Behavior Levels of Newborns With Artificial Intelligence Techniques
|
N/A | |
Completed |
NCT01732978 -
Are Parents Privileged Listeners Their Baby ?
|
N/A | |
Unknown status |
NCT01029496 -
Immediate VS Delayed Cord Clamping on Newborns
|
Phase 1/Phase 2 | |
Recruiting |
NCT06032494 -
Investigating Changes in Vital Signs in Neonates
|
||
Completed |
NCT03690804 -
Assessment of Autonomic Co-regulation Between Newborn and Parent During Kangaroo Care Sessions in Neonatal Intensive Care Units
|
N/A | |
Completed |
NCT05064683 -
The Effect of Facilitated Tucking and White Noise on Stress and Sleep of Newborns in Nasal CPAP
|
N/A | |
Completed |
NCT04827849 -
Theory of Meleis on Women's Adaptation to Motherhood and Perceptions of Newborn Baby
|
N/A | |
Not yet recruiting |
NCT03630575 -
Study of Psychoactive Substances in Newborns' Hair Whose Mothers Were Treated and Followed at the Nice University Hospital - New Born Hair Study
|
N/A | |
Recruiting |
NCT03109444 -
Normative Radiographic Parameters and Growth Curve of Hips Less Than Six Weeks of Gestational Age Using Ultrasound
|
||
Not yet recruiting |
NCT06053931 -
The Effect of Music on Neonatal Stress, Mother's Breastfeeding Success and Comfort
|
N/A | |
Completed |
NCT04869176 -
Effect of Caffeine on Heart Rate Variability in Newborns
|
N/A | |
Completed |
NCT05103800 -
Investigation of the Effect of White Noise Listening on Pain and Comfort During Invasive Interventions in Newborns
|
N/A | |
Not yet recruiting |
NCT05109481 -
Masks and Visual Preferences in the Newborn
|
||
Completed |
NCT03047967 -
Effects of Prenatal Tobacco Smoke Exposure on Lung Function and Respiratory Epithelium Functionality in Newborns
|
N/A | |
Not yet recruiting |
NCT06418815 -
Concept Map on Toxic Stress in Newborns
|
N/A | |
Completed |
NCT03969459 -
Impact of Exposure to Persistent Organic Pollutants During Pregnancy on the Composition of Breast Milk and Consequences on the Newborn
|
||
Completed |
NCT06352918 -
Peripheral Central Catheter (PICC) Care
|
N/A | |
Completed |
NCT05442619 -
Developing a Portable Therapeutic Baby Nest for Newborns and Evaluation During Venous Blood Collection
|
N/A |